Clinical Trial Update: Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity [Phase 4]

View source ↗

Summary

Phase 4 study assessing the efficacy and tolerability of dolutegravir plus lamivudine in HIV-infected adults with virologic suppression and tenofovir toxicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• DTG plus 3TC

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: Acquired Immunodeficiency Syndrome | Phase 4 | Status: NOT_YET_RECRUITING